Literature DB >> 216349

Action of liproprotein lipase on apoprotein-depleted chylomicrons.

T W Lukens, J Borensztajn.   

Abstract

1. Rat lymph chylomicrons were exposed to soluble and to immobilized trypsin. This treatment caused no detectable changes in the chylomicron structure or lipid composition, but did result in virtually total depletion of all their tetramethylurea-soluble apoproteins. 2. The capacity of these apoprotein-depleted chylomicrons to act as substrate for lipoprotein lipase in vitro and in situ (i.e. isolated perfused rat heart) was decreased by about 90 and 75% respectively, compared with intact chylomicrons. 3. On incubation with rat plasma high-density lipoproteins, trypsin-treated chylomicrons readily acquired a full apoprotein complement. This resulted in the complete restoration of their capacity to act as substrate for lipoprotein lipase both in vitro and in situ. 4. It is suggested that with the use of try,sin-treated chylomicrons it is now possible for the first time to investigate the physiological role that individual apoproteins play in the catabolism of triacylglycerol-rich lipoproteins by lipoprotein lipase.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 216349      PMCID: PMC1186040          DOI: 10.1042/bj1750053

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  PROTEOLYSIS OF HUMAN SERUM BETA-LIPOPROTEIN.

Authors:  P BERNFELD; T F KELLEY
Journal:  J Biol Chem       Date:  1964-10       Impact factor: 5.157

2.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

3.  Characterization of remnants produced during the metabolism of triglyceride-rich lipoproteins of blood plasma and intestinal lymph in the rat.

Authors:  O D Mjos; O Faergeman; R L Hamilton; R J Havel
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

4.  The effect of human arginine rich apoprotein on rat adipose lipoprotein lipase.

Authors:  S H Quarfordt; H Hilderman; M R Greenfield; F A Shelburne
Journal:  Biochem Biophys Res Commun       Date:  1977-09-09       Impact factor: 3.575

5.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

6.  Clearing factor lipase (lipoprotein lipase) activator. A method for the measurement of the net activating ability of human sera.

Authors:  M P Rogers; D Barnett; D S Robinson
Journal:  Atherosclerosis       Date:  1976-09       Impact factor: 5.162

7.  A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins.

Authors:  J P Kane
Journal:  Anal Biochem       Date:  1973-06       Impact factor: 3.365

8.  Adsorbents for affinity chromatography. Use of N-hydroxysuccinimide esters of agarose.

Authors:  P Cuatrecasas; I Parikh
Journal:  Biochemistry       Date:  1972-06-06       Impact factor: 3.162

9.  A specific apoprotein activator for lipoprotein lipase.

Authors:  J C LaRosa; R I Levy; P Herbert; S E Lux; D S Fredrickson
Journal:  Biochem Biophys Res Commun       Date:  1970-10-09       Impact factor: 3.575

10.  Is decreased activity of C-II activated lipoprotein lipase in type III hyperlipoproteinemia (broad-beta-disease) a cause or an effect of increased apolipoprotein E levels?

Authors:  D Ganesan; H B Bass; W J McConathy; P Alaupovic
Journal:  Metabolism       Date:  1976-11       Impact factor: 8.694

View more
  5 in total

1.  Hydrolysis of chylomicron triacylglycerol by endothelium-bound lipoprotein lipase. Effect of decreased apoprotein C-II/C-III ratio.

Authors:  T J Kotlar; J Borensztajn
Journal:  Biochem J       Date:  1979-10-01       Impact factor: 3.857

2.  Effects of C apoproteins on the activity of endothelium-bound lipoprotein lipase.

Authors:  T W Lukens; J Borensztajn
Journal:  Biochem J       Date:  1978-12-01       Impact factor: 3.857

3.  The apoprotein B-independent hepatic uptake of chylomicron remnants.

Authors:  J Borensztajn; G S Getz; R J Padley; T J Kotlar
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

4.  Liver uptake of chylomicron remnants with high and low apoprotein E:C ratios.

Authors:  J Borensztajn; T J Kotlar
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

5.  Heparin-binding apoproteins. Effects on lipoprotein lipase and hepatic uptake of remnants.

Authors:  J Borensztajn; T J Kotlar; C A Matza
Journal:  Biochem J       Date:  1986-02-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.